ST 520 Statistical Principles of Clinical Trials - NCSU Statistics ...
ST 520 Statistical Principles of Clinical Trials - NCSU Statistics ...
ST 520 Statistical Principles of Clinical Trials - NCSU Statistics ...
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
CHAPTER 10 <strong>ST</strong> <strong>520</strong>, A. TSIATIS and D. Zhang<br />
information necessary to achieve a certain level <strong>of</strong> significance and power for a fixed sample<br />
design and multiplying by an inflation factor. For designs with a maximum <strong>of</strong> K analyses after<br />
equal increments <strong>of</strong> information, the inflation factor is a function <strong>of</strong> α (the significance level), β<br />
(the type II error or one minus power), K, and Φ (the shape parameter <strong>of</strong> the boundary). We<br />
denote this inflation factor by IF(α, K, Φ, β).<br />
Let V denote the number <strong>of</strong> interim analyses conducted before a study is stopped. V is a discrete<br />
integer-valued random variable that can take on values from 1, . . ., K. Specifically, for a K-look<br />
group-sequential test with boundaries b1, . . .,bK, the event V = j (i.e. stopping after the j-th<br />
interim analysis) corresponds to<br />
(V = j) = {|T(t1)| < b1, . . ., |T(tj−1)| < bj−1, |T(tj)| ≥ bj}, j = 1, . . ., K.<br />
The expected number <strong>of</strong> interim analyses for such a group-sequential test, assuming ∆ = ∆ ∗ is<br />
given by<br />
E∆∗(V ) =<br />
K�<br />
j=1<br />
j × P∆∗(V = j).<br />
Since each interim analysis is conducted after increments MI/K <strong>of</strong> information, this implies that<br />
the average information before a study is stopped is given by<br />
Since MI = I FS × IF(α, K, Φ, β), then<br />
AI(α, K, Φ, β, ∆ ∗ ) = I FS<br />
AI(∆ ∗ ) = MI<br />
E∆∗(V ).<br />
K<br />
�� �<br />
IF(α, K, Φ, β)<br />
K<br />
E∆∗(V )<br />
Note: We use the notation AI(α, K, Φ, β, ∆ ∗ ) to emphasize the fact that the average information<br />
depends on the level, power, maximum number <strong>of</strong> analyses, boundary shape, and alternative <strong>of</strong><br />
interest. For the most part we will consider the average information at the null hypothesis ∆ ∗ = 0<br />
and the clinically important alternative ∆ ∗ = ∆A. However, other values <strong>of</strong> the parameter may<br />
also be considered.<br />
Using recursive numerical integration, the E∆∗(V ) can be computed for different sequential de-<br />
signs at the null hypothesis, at the clinically important alternative ∆A, as well as other values<br />
for the treatment difference. For instance, if we take K = 5, α = .05, power equal to 90%,<br />
then under HA : ∆ = ∆A, the expected number <strong>of</strong> interim analyses for a Pocock design is<br />
PAGE 190<br />
�<br />
.